Профилактика ранних рецидивов фибрилляции предсердий у пациентов после абляции по поводу персистирующей формы фибрилляции предсердий

Коженов А.Т., Азизов С.Н., Хузиахметов Р.Д., Мусаев О.Г., Арутюнян В.Б.

На сегодняшний день фибрилляция предсердий является наиболее распространенной аритмией сердца. Распространенность этого заболевания в общей популяции составляет около 1–2% и, вероятнее всего, будет увеличиваться в ближайшие 50 лет. Фибрилляция предсердий сопровождается увеличением частоты развития инсульта и других тромбоэмболических осложнений, развития сердечной недостаточности, частоты госпитализации, ухудшением качества жизни, снижением толерантности к физической нагрузке. Невысокая эффективность лечения персистирующей формы фибрилляции предсердий, частые рецидивы после интервенционного лечения обуславливают поиски оптимального варианта лечения. В статье рассматриваются основные варианты радиочастотной катетерной абляции по поводу персистирующей формы фибрилляции предсердий, а также способы профилактики ранних рецидивов фибрилляции предсердий. Влияние антиаритмической терапии на профилактику ранних рецидивов фибрилляции предсердий после катетерной абляции. Возможность оценки эффективности антиаритмической терапии в зависимости от эффективного рефрактерного периода левого предсердия.

1. Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew. Paisley study. Heart. 2001; 86: 516-521. doi: 10.1136/heart.86.5.516.

2. Le Heuzy JY, Paziaud О, Piot О, et al. Cost of care distribution in atrial fibrillation patients: The COCAF study. Am Heart J. 2004; 147: 121-126. doi: 10.1016/s0002-8703(03)00524-6.

3. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. N Engl J Med. 2002; 347: 1825-33. doi: 10.1056/NEJMoa021328.

4. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019; 321(13): 1261-1274. doi: 10.1001/jama.2019.0693.

5. Mark DB, Anstrom KJ, Sheng S, et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019; 321(13): 1275-1285. doi: 10.1001/jama.2019.0692.

6. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am CollCardiol. 2006; 48(11): 2340-2347. doi: 10.1016/j.jacc.2006.08.037.

7. Pappone C, Oreto G, Lamberti F, et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation. 1999; 100(11): 1203-1208. doi: 10.1161/01.cir.100.11.1203.

8. Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation. 2001; 104(21): 2539-2544. doi: 10.1161/hc4601.098517.

9. Ganesan AN, Shipp NJ, Brooks AG, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013; Vol. 2(2): e004549. doi: 10.1161/JAHA.112.004549.

10. Ревишвили А.Ш., Нардая Ш.Г., Рзаев Ф.Г., и др. Электрофизиологические и клинические предикторы эффективности радиочастотной аблации легочных вен и левого предсердия у пациентов с персистирующей формой фибрилляции предсердий // Анналы аритмологии. — 2014. — Т.11 — №1. — С. 46-53. doi: 10.15275/annaritmol.2014.1.6.

11. Haissaguerre M, Hocini M, Denis A, et al. Driver domains in persistent atrial fibrillation. Circulation. 2014; 130(7): 530-538. doi: 10.1161/ CIRCULATIONAHA.113.005421.

12. Mohanty S, Mohanty P, Trivedi Ch, et al. Long-term outcome of pulmonary vein isolation with and without focal impulse and rotor modulation mapping insights from a meta-analysis. Circ Arrhythm Electrophysiol. 2018; 11(3): e005789. doi: 10.1161/CIRCEP.117.005789.

13. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004; 43(11): 2044-2053. doi: 10.1016/j.jacc.2003. 12.054.

14. Providência R, Lambiase PD, Srinivasan N, et al. Is there still a role for complex fractionated atrial electrogram ablation in addition to pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation? Meta-analysis of 1415 patients. Circ Arrhythm Electrophysiol. 2015; 8(5): 1017-1029. doi: 10.1161/CIRCEP.115.003019.

15. Haissaguerre M, Sanders P, Hocini P, et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol. 2005; 16(11): 1125-1137. doi: 10.1111/ j. 1540-8167.2005.00307.x.

16. Vogler J, Willems S, Sultan A, et al. Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol. 2015; 66(24): 2743-2752. doi: 10.1016/j.jacc.2015.09.088.

17. Martin CA, Curtain JP, Gajendragadkar PR, et al. Ablation of complex fractionated electrograms improves outcome in persistent atrial fibrillation of over 2 year’s duration. J Atr Fibrillation. 2018; 10(5): 1607. doi: 10.4022/ jafib.1607.

18. Wong KC, Paisey R, Sopher M, et al. No benefit of complex fractionated atrial electrogram ablation in addition to circumferential pulmonary vein ablation and linear ablation: Benefit of Complex Ablation study. Circ Arrhythm Electrophysiol. 2015; 8(6): 1316-1324. doi: 10.1161/CIRCEP.114.002504.

19. Mahnkopf Ch, Badger TJ, Burgon NS, et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm. 2010; 7(10): 1475-1481. doi: 10.1016/j.hrthm.2010.06.030.

20. Jadidi AS, Lehrmann H, Keyl C, et al. Ablation of persistent atrial fibrillation targeting low-voltage areas with selective activation characteristics. Circ Arrhythm Electrophysiol. 2016; 9(3): e002962. doi: 10.1161/CIRCEP. 115.002962.

21. Bisbal F, Benito E, Teis A, et al. Magnetic resonance imaging-guided fibrosis ablation for the treatment of atrial fibrillation: the ALICIA trial. Circ Arrhythm Electrophysiol. 2020; 13(11): e008707. doi: 10.1161/CIRCEP.120.008707.

22. Yang B, Jiang Ch, Lin Y, et al. STABLE-SR (electrophysiological substrate ablation in the left atrium during sinus rhythm) for the treatment of nonparoxysmal atrial fibrillation: a prospective, multicenter randomized clinical trial. Circ Arrhythm Electrophysiol. 2017; 10(11): e005405. doi: 10.1161/CIRCEP.117.005405.

23. Lin H, Chen YH, Hou JW, et al. Role of contact force guided radiofrequency catheter ablation for treatment of atrial fibrillation : a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2017; 28 (9): 994-1005. doi: 10.1111/jce.13264.

24. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace. 2018; 20(1): 157-208. doi: 10.1093/europace/eux275.

25. Themistoclakis S, China P. Early Recurrences of Atrial Tachyarrhythmias After Ablation of Atrial Fibrillation: How Long Do We Have to Be Blind? JACC Clin Electrophysiol. 2017; 3(6): 577-579. doi: 10.1016/j.jacep.2017.03.012.

26. Andrade JG, Khairy P, Verma A, et al. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012; 35(1): 106-116. doi: 10.1111/j.1540-8159.2011.03256.x.

27. Alipour P, Azizi Z, Pirbaglou M, et al. Defining Blanking Period Post-Pulmonary Vein Antrum Isolation. JACC Clin Electrophysiol. 2017; 3(6): 568-576. doi: 10.1016/j.jacep.2017.01.006.

28. Themistoclakis S, Schweikert RA, Saliba WI, et al. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm. 2008; 5(5): 679-85. doi: 10.1016/ j.hrthm.2008.01.031.

29. Bertaglia E, Stabile G, Senatore G, et al. Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation. Pacing Clin Electrophysiol. 2005; 28(5): 366-71. doi: 10.1111/j.1540-8159.2005.09516.x.

30. Andrade JG, Macle L, Khairy P, et al. Incidence and significance of early recurrences associated with different ablation strategies for AF: a STAR-AF substudy. J Cardiovasc Electrophysiol. 2012; 23(12): 1295-301. doi: 10.1111/j.1540-8167.2012.02399.x.

31. Kim YG, Boo KY, Choi JI, et al. Early Recurrence Is Reliable Predictor of Late Recurrence After Radiofrequency Catheter Ablation of Atrial Fibrillation Catheter Ablation: Atrial Arrhythmias/Atrial Fibrillation. J Am Coll Cardiol EP. 2021; 7(3): 343-351. doi: 10.1016/j.jacep.2020.09.029.

32. Das M, Wynn GJ, Morgan M, et al. Recurrence of atrial tachyarrhythmia during the second month of the blanking period is associated with more extensive pulmonary vein reconnection at repeat electrophysiology study. Circ Arrhythm Electrophysiol. 2015; 8(4): 846-52. doi: 10.1161/CIRCEP. 115.003095.

33. Mujović N, Marinković M, Marković N, et al. The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set. Sci Rep. 2018; 8(1): 9875. doi: 10.1038/s41598-018-28072-y.

34. Roux JF, Zado E, Callans DJ, et al. Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study). Circulation. 2009; 120(12): 1036-1040. doi: 10.1161/CIRCULATIONAHA.108.839639.

35. Darkner S, Chen Xu, Hansen J, et al. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial). Eur Heart J. 2014; 35(47): 3356-64. doi: 10.1093/eurheartj/ehu354.

36. Kaitani K, Inoue K, Kobori A, et al. Efficacy of antiarrhythmic drugs short-term use after catheter ablation for atrial fibrillation (EAST-AF) trial. Eur Heart J 2016; 37(7): 610-618. doi: 10.1093/eurheartj/ehv501.

37. Goldenberg GR, Burd D, Lodzinski P, et al. Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success-a meta-analysis. J Interv Card Electrophysiol. 2016; 47(2): 171-176. doi: 10.1007/ s10840-016-0157-y.

38. Chen W, Liu H, Ling Z, et al. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials. PLoS One. 2016; 11(5): e0156121. doi: 10.1371/journal.pone. 0156121.

39. Xu X, Alida CT, Yu B. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis. Cardiovasc Ther. 2015; 33(4): 242-6. doi: 10.1111/1755-5922.12133.

40. Lei M, Gong M, Bazoukis G, et al. Steroids prevent early recurrence of atrial fibrillation following catheter ablation: a systematic review and meta-analysis. Biosci Rep. 2018; 38(5): BSR20180462. doi: 10.1042/BSR20180462.

41. Deftereos S, Giannopoulos G, Efremidis M, et al. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm. 2014; 11(4): 620-8. doi: 10.1016/j.hrthm.2014.02.002.

42. Тарасов А.В., Давтян К.В., Марцевич С.Ю. Cравнение эффективности антиаритмической терапии в послеоперационном периоде катетерной изоляции устьев легочных вен для профилактики ранних рецидивов предсердных тахиаритмий в рамках исследования ПРУФ. Рациональная Фармакотерапия в Кардиологии. — 2017. — T.13(1). — C.18-24. doi: 10.20996/1819-6446-2017-13-1-18-24.

43. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54(2): 230-246. doi: 10.1016/s0008-6363(02)00258-4.

44. Spach MS, Barr RC, Jewett PH. Spread of excitation from the atrium into thoracic veins in human beings and dogs. Am J Cardiol. 1972; 30(8): 844–854.

45. Bokeriya LA, Bazaev VA, Filatov AG, et al. Electrophysiological study in atrial fibrillation. Annals of Arrhythmology 2006; 6: 48-58.